During the past decade, SignatureCare Emergency Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SignatureCare Emergency Center" are "COVID-19" (2 trials). Many other conditions were trialed in "SignatureCare Emergency Center" in a lesser frequency.

Most popular intervention types in "SignatureCare Emergency Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "PF-07321332" (2 trials), "Placebo" (2 trials) and "Ritonavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "SignatureCare Emergency Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "SignatureCare Emergency Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in SignatureCare Emergency Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in SignatureCare Emergency Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".